Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

HIV treatment news

Show

From To
Drug that reduces abdominal fat in HIV patients also may reduce fat in liver

The only drug to receive Food and Drug Administration approval for reduction of the abdominal fat deposits that develop in some patients receiving antiviral therapy for HIV infection may also reduce the incidence of fatty liver disease in such patients. Massachusetts General Hospital investigators report that six months of daily injections of tesamorelin significantly reduced fat in the liver without affecting glucose metabolism.

Published
19 July 2014
From
Eurekalert Medicine & Health
Wrestling with the Implications of the Mississippi Case

The sobering outcome in Mississippi further emphasizes that the absence of detectable HIV cannot be assumed to mean the virus has been cleared.

Published
14 July 2014
From
Treatment Action Group
Three Top Researchers Question Efavirenz Status as First-Line Agent

Looking at recent evidence, three top clinical investigators question whether the nonnucleoside efavirenz should maintain its rank as a preferred first-line antiretroviral.

Published
14 July 2014
From
International AIDS Society
High levels of adherence to study medication among women who conceived during HIV PrEP study

HIV pre-exposure prophylaxis (PrEP) appears to be an acceptable strategy for safer conception for HIV-negative women in a relationship with an HIV-positive partner, according to

Published
14 July 2014
By
Michael Carter
High rates of drug resistance among HIV-positive infants in South Africa

There was a high prevalence of antiretroviral drug resistance among infants newly diagnosed with HIV in Johannesburg, investigators report in AIDS. Over half the infants

Published
13 July 2014
By
Michael Carter
Therapy with newer, safer antiretrovirals an option for the majority of HIV-positive patients

The majority of people taking antiretroviral therapy (ART) that includes drugs associated with long-term side-effects may have the option of switching to a novel regimen

Published
11 July 2014
By
Michael Carter
HIV re-emerges in 'cured' US girl

A child born in the US with HIV and believed cured after very early treatment has now been found to still harbour the virus, doctors say.

Published
11 July 2014
From
BBC Health
Switch from single-tablet regimen to 3 tablets works in Denmark

Switching from an efavirenz-containing single-tablet regimen (STR) to an efavirenz containing triple-tablet regimen (TTR) to save money maintained viral suppression in Denmark. Antiretroviral-naive people who started the TTR attained the same virologic suppression rate as people who started the STR combination.

Published
10 July 2014
From
International AIDS Society
Egypt's Military Regime Still Pushing Bogus HIV, Hepatitis "Cure"

The so-called 'miracle' device originally made media headlines in February when it was slammed for its tenuous grasp of the science surrounding both life-threatening diseases.

Published
09 July 2014
From
Poz magazine news
Option B+: In obstacle courses to lifelong antiretroviral treatment, hurdles are higher for pregnant women, study says

Work conflicts, hidden HIV status, and bad treatment by staff are among the hurdles keeping women living with HIV from continuing antiretroviral treatment for life following childbirth, according to a article published last month ahead of print in the Journal of Acquired Immune Deficiency Syndromes.

Published
09 July 2014
From
Science Speaks

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.